Cargando…
Generation and characterization of new monoclonal antibodies targeting the PHF1 and AT8 epitopes on human tau
Tauopathies are a group of neurodegenerative disorders, including Alzheimer’s disease, defined by the presence of brain pathological inclusions comprised of abnormally aggregated and highly phosphorylated tau protein. The abundance of brain tau aggregates correlates with disease severity and select...
Autores principales: | Strang, Kevin H., Goodwin, Marshall S., Riffe, Cara, Moore, Brenda D., Chakrabarty, Paramita, Levites, Yona, Golde, Todd E., Giasson, Benoit I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5537986/ https://www.ncbi.nlm.nih.gov/pubmed/28760159 http://dx.doi.org/10.1186/s40478-017-0458-0 |
Ejemplares similares
-
Novel monoclonal antibodies targeting the microtubule-binding domain of human tau
por: Croft, Cara L., et al.
Publicado: (2018) -
Designing antibodies against LRRK2-targeted tau epitopes
por: Hamm, Matthew, et al.
Publicado: (2018) -
A novel panel of α-synuclein antibodies reveal distinctive staining profiles in synucleinopathies
por: Dhillon, Jess-Karan S., et al.
Publicado: (2017) -
Anti-tau scFvs Targeted to the Cytoplasm or Secretory Pathway Variably Modify Pathology and Neurodegenerative Phenotypes
por: Goodwin, Marshall S., et al.
Publicado: (2021) -
rAAV-based brain slice culture models of Alzheimer’s and Parkinson’s disease inclusion pathologies
por: Croft, Cara L., et al.
Publicado: (2019)